Translucence Biosystems Attends and Sponsors FLAIR 2026 Workshop at UC Irvine

by
Angela Prvulovic
January 19, 2026

Translucence Biosystems recently attended and sponsored the Fluorescence Advanced Imaging Research (FLAIR) Workshop, held January 12–15, 2026, at the University of California, Irvine. The workshop was a combination of UC Irvine’s Laboratory for Fluorescence Dynamics (LFD) workshop and UC Berkeley’s Advanced Imaging Methods (AIM) workshop.

During the event, the Translucence team connected with researchers building advanced microscopy workflows and shared guidance on sample preparation, imaging, and analysis for 3D histology. The team also hosted live daily demonstrations of the Mesoscale Imaging System™ on the ZEISS Lightsheet Z.1 at UC Irvine’s Optical Biology Core Facility.

At FLAIR, Translucence discussed how it is helping enable the next-generation histology shift toward intact-tissue, 3D workflows through an integrated suite of products, services, and software spanning tissue clearing and staining, light sheet imaging, large-volume stitching, and downstream quantification. Translucence’s offerings include tissue clearing kits, the Mesoscale Imaging System™ for acquisition, Stitchy™ for 3D stitching, and full-pipeline services.

Researchers who met the team at FLAIR or who would like support planning or troubleshooting a clearing-to-analysis workflow can contact Translucence Biosystems at info@translucencebio.com.

Ask your question

Send us your questions and we will get back to you as soon as possible
info@translucencebio.com

Thank you! Your submission has been received!
Something went wrong while submitting the form.
Please, contact via us direct email info@translucencebio.comand

Recent news

August 13, 2025
Updates

AAIC25 Highlights: Translucence Biosystems Showcases Tools for 3D Whole-Brain Quantification of Alzheimer’s Pathology and Therapeutic Distribution

Translucence Biosystems recently participated in the Alzheimer's Association International Conference® (AAIC25), where CEO Damian Wheeler presented two posters demonstrating Translucence's whole-brain 3D tissue clearing techniques and AI-powered quantification pipeline. These presentations highlighted next-generation methodologies for quantifying disease burden and mapping therapeutic biodistribution at cellular resolution across the entire brain.
by
Angela Prvulovic
May 12, 2025
Updates

Translucence Biosystems hosts Lunch and Learn Event in Partnership with the UC Berkeley Molecular Imaging Core

Translucence Biosystems hosted an informative Lunch and Learn event in collaboration with the Molecular Imaging Center at the UC Berkeley Cancer Research Lab on Wednesday, April 9th, 2025.
by
Angela Prvulovic
February 25, 2025
Updates

CEO Damian Wheeler Presents on Brain-Wide Parenchymal Quantification of BBB-Crossing Antibody Therapeutics at Keystone Symposia 2025

Translucence Biosystems CEO Damian Wheeler, presented at the Drug Delivery to the Brain: Emerging Modalities Keystone Symposia meeting held on February 17–20, 2025.
by
Angela Prvulovic